Cliff Asness’s Regulus Therapeutics RGLS Stock Holding History

Cliff Asness’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-68,580	Closed	-$120K	–	3378
2025 Q1	$120K	Buy	+68,580	New	+$90.5K	﹤0.01%	2978
2024 Q4	–	Sell	-30,209	Closed	-$47.4K	–	2934
2024 Q3	$47.4K	Buy	+30,209	New	+$50K	﹤0.01%	2709
2015 Q4	–	Sell	-426	Closed	-$335K	–	2291
2015 Q3	$335K	Sell	426 -170	-29%	-$174K	﹤0.01%	1882
2015 Q2	$783K	Buy	596 +192	+48%	+$310K	﹤0.01%	1616
2015 Q1	$822K	Buy	404 +151	+60%	+$328K	﹤0.01%	1504
2014 Q4	$488K	Buy	+253	New	+$450K	﹤0.01%	1976

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cliff Asness's RGLS Position: Q2 2025 in Review

Cliff Asness sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 68,580 shares — an estimated $120K sold.

Cliff Asness first reported a position in RGLS in Q4 2014 and held it in 6 quarters. The position peaked at $822K in Q1 2015. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

Cliff Asness reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
Cliff Asness sold 68,580 Regulus Therapeutics shares in Q2 2025, an estimated $120K.
Cliff Asness first reported a position in Regulus Therapeutics in Q4 2014 and held it in 6 quarters.
Cliff Asness's Regulus Therapeutics position peaked at $822K in Q1 2015.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.